These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1141 related articles for article (PubMed ID: 31074374)

  • 1. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
    Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
    Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.
    Zou J; Du K; Li S; Lu L; Mei J; Lin W; Deng M; Wei W; Guo R
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Bulk RNA Sequencing Data Reveals Novel Transcription Factors Associated With Immune Infiltration Among Multiple Cancers.
    Liu L; Zhao Q; Cheng C; Yi J; Sun H; Wang Q; Quan W; Xue Y; Sun L; Cong X; Zhang Y
    Front Immunol; 2021; 12():644350. PubMed ID: 34489925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
    Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
    Front Immunol; 2021; 12():812713. PubMed ID: 35069601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
    Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
    Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MS4A1 as a Potential Independent Prognostic Factor of Breast Cancer Related to Lipid Metabolism and Immune Microenvironment Based on TCGA Database Analysis.
    Li S; Fang Y
    Med Sci Monit; 2022 Jan; 28():e934597. PubMed ID: 35091527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities.
    Chen Y; Xiao C; Fan Q; Zhang Y; Huang Q; Ou Y
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):151. PubMed ID: 38682182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
    Yang X; Miao Y; Wang J; Mi D
    Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
    Xu HH; Gan J; Xu DP; Li L; Yan WH
    Front Immunol; 2021; 12():614773. PubMed ID: 34276642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the role of AGT in lipid metabolism and regulated cell death in colon cancer.
    Wu M; Zhou Y; Pei D; Gao S
    Neoplasia; 2024 Aug; 54():101009. PubMed ID: 38850836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
    Chang WH; Lai AG
    BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics analysis identifies BCAT2 as a potential pan-cancer biomarker for tumor progression and immune microenvironment modulation.
    Cao Q; Fan J; Zou J; Wang W
    Sci Rep; 2024 Oct; 14(1):23371. PubMed ID: 39375392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
    Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
    BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of stearoyl-coenzyme A desaturase in prostate adenocarcinoma: insights into gene expression, immune microenvironment and tumor progression.
    Wang J; Ying L; Xiong H; Zhou DR; Wang YX; Che HL; Zhong ZF; Wu GS; Ge YJ
    Front Immunol; 2024; 15():1460915. PubMed ID: 39351232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.
    Yuan Z; Li B; Liao W; Kang D; Deng X; Tang H; Xie J; Hu D; Chen A
    Front Immunol; 2024; 15():1382520. PubMed ID: 38698857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pan-cancer mutational landscape of the PPAR pathway reveals universal patterns of dysregulated metabolism and interactions with tumor immunity and hypoxia.
    Chang WH; Lai AG
    Ann N Y Acad Sci; 2019 Jul; 1448(1):65-82. PubMed ID: 31215667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the role of Frizzled 2 in different cancer types.
    Zhou M; Sun X; Zhu Y
    FEBS Open Bio; 2021 Apr; 11(4):1195-1208. PubMed ID: 33565732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.